Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 18 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
Q3 2022 vs. Q2 2022
How the institutions holding Revolution Medicines, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 135 | 142 | +7 |
| Shares | 76.5M | 88.4M | +11.9M (+15.6%) |
| Value | $1.49B | $1.74B | +$252.3M (+16.9%) |
New holders (23)
Institutions that held Revolution Medicines, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (16)
Institutions that held Revolution Medicines, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Thunderbird Partners LLP | 344,324 | $6.71M |
| Tri Locum Partners LP | 148,453 | $2.89M |
| HRT Financial LP | 94,448 | $1.84M |
| Jump Financial, LLC | 63,800 | $1.24M |
| Gsa Capital Partners LLP | 42,184 | $822.0K |
| Point72 Asset Management, L.P. | 27,667 | $539.0K |
| Trexquant Investment LP | 25,212 | $491.0K |
| Tudor Investment Corp Et Al | 22,998 | $448.0K |
| Ergoteles LLC | 16,600 | $324.0K |
| Aristides Capital LLC | 14,581 | $284.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 12,033 | $235.0K |
| Dynamic Technology Lab Private Ltd | 10,572 | $206.0K |
| Point72 Hong Kong Ltd | 1,998 | $39.0K |
| Howe & Rusling Inc | 30 | $1.00K |
| Parallel Advisors, LLC | 13 | $0 |
| State of Wyoming | 19 | $0 |